PREX1 and non-small cell lung carcinoma: Collectively, through the analysis using Oncomine, GEPIA, UALCAN, and Kaplan–Meier Plotter databases, consistent results highlight the downregulation of ABR, PREX1, DOCK2, and DOCK4 in NSCLC, and they notably predict the poor prognosis of NSCLC patients.